About the Research Roundtable for Epilepsy

The Research Roundtable for Epilepsy (RRE) is an initiative of the Epilepsy Foundation to facilitate the development and implementation of new treatments and diagnostic tools for people with epilepsy, by collectively addressing roadblocks to research and development. 

Each roundtable focuses on a single critical issue, and allows an in-depth discussion in a pre-competitive space. Our consortium is composed of senior scientists from pharmaceutical, biotechnology, and diagnostic companies as well as regulatory agencies such as the U.S. Food and Drug Administration and the European Medicines Agency and patient organizations. All proceeding outcomes are written and published in a well-regarded academic journal to be shared with the broader community.

Interested in Participating?

Companies that are involved in developing products for the treatment or diagnosis of epilepsy are invited to become members of the RRE. Companies that accept will select 3 representatives to attend the Roundtable meeting. 

For additional information about the Research Roundtable for Epilepsy, please contact Dr. Caitlin Grzeskowiak at 

Save the Date: 2022 Research Roundtable

May 19-20, 2022

Past Roundtables

Seizure types and epilepsy syndromes: opportunity or obstable?

April 8-9, 2021, Virtual Meeting

"Approval for Focal Epilepsy Drugs for Infants" and "innovative data capture including electronic seizure diaries"

May 14-15, 2020, Virtual Meeting

Efficient Trials in Epilepsy

March 21-22, 2019, Washington, D.C.

Evolving Concepts in Endpoints and Populations in Epilepsy Trials

May 17-18, 2018, Washington D.C.

Pediatric Drug Development: Moving Toward a Framework for Antiepileptic Drug Use in Children

March 2-3, 2017, Washington, D.C.

New Trial Designs to Reduce Participants' Exposure to Add-On Placebo and Ineffective Doses of Experimental Therapies

May 19-20, 2016, Washington, D.C.